Table 2.
NYT (%) | Control (%) | P | |
Enrolled cases | 10 | 13 | |
Normal ALT at the end of therapy | 7 (70.0) | 6 (46.2) | 0.253 |
Negative HCVRNA at the end of therapy | 8 (80.0) | 7 (53.8) | 0.192 |
Normal ALT 6 mo after therapy | 8 (80.0) | 4 (30.8) | 0.489 |
Negative HCVRNA 6 mo after therapy | 4 (40.0) | 4 (30.8) | 0.645 |